mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.001 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |